Skip to main content
SpringerLink
Log in

Mesalazine in Crohn’s disease

limited benefits at small cost

  • Newsletter Article
  • Published:
PharmacoEconomics & Outcomes News Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mesalazine in Crohn’s disease. Pharmacoecon. Outcomes News 114, 9 (1997). https://doi.org/10.1007/BF03271651

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03271651

Keywords

Search

Navigation